HOME >> BIOLOGY >> NEWS
Burnham Institute for Medical Research announces affiliation with UC Santa Barbara

(La Jolla and Santa Barbara, California December 12, 2006) -- The Burnham Institute for Medical Research ("Burnham") has established an affiliation with the University of California, Santa Barbara led by internationally-renowned medical researcher Erkki Ruoslahti, M.D., Ph.D, the campus and the Institute announced today. Dr. Ruoslahti maintains his primary appointment as Distinguished Professor with the Burnham, and joins UCSB's Department of Molecular, Cellular and Developmental Biology as an adjunct Distinguished Professor.

At Burnham-UCSB, Ruoslahti has opened the "Vascular Mapping Center", which will focus on developing applications for vascular "zip codes," based on technology discovered in his laboratory. Vascular zip codes are molecular signatures in blood and lymphatic vessels ("vasculature") that are specific to individual tissues and disease sites. Ruoslahti has discovered ways to selectively target drugs to tumor blood vessels in mice and suppress the growth of those tumors. He has also found a way to selectively target the lymphatic vessels in tumors. The hope is that this very specific delivery of therapeutics to tumor blood and lymphatic vessels will increase the efficacy of cancer therapies and decrease side effects.

Targeting peptides discovered in Ruoslahti's laboratory are providing the platform for integrating nanotechnologies into the design of new therapies for cancer and heart disease. Ruoslahti and others at Burnham contribute a key component to the Center of Cancer Nanotechnology Excellence at the University of California, San Diego founded with $20 million from the National Cancer Institute.

A partnership of 25 scientists, primarily from Burnham and UCSB, has been recognized by the National Institutes of Health as a "Program of Excellence in Nanotechnology", awarding a $13 million grant to design nanotechnologies that detect, monitor, treat, and eliminate "vulnerable" plaque, the probable cause of deat
'"/>

Contact: Nancy Beddingfield
nbeddingfield@burnham.org
858-646-3146
Burnham Institute
12-Dec-2006


Page: 1 2

Related biology news :

1. NIH awards $7.39 million to Burnham neurobiologists
2. CIRM awards $6M to Burnham Institute
3. CIRM awards $5.9 million to Burnham Institute
4. Burnham awarded $12.7 million from NIH to create one of nations top neuroscience research centers
5. Burnham Institute for Medical Research & UC San Diego establish Joint Center for Molecular Modeling
6. Burnham to collaborate on NCI-funded task force to find molecular signature for prostate cancer
7. Burnham Institute to collaborate in NCI funded Center of Cancer Nanotechnology Excellence
8. NFCR - Prostate Cancer Foundation unite with Burnham Institute to expedite cancer drug discovery
9. NIH selects Burnham Institute for Exploratory Center for Human Embryonic Stem Cell Research
10. Anthrax inhibitors identified by Burnham team
11. NIH awards $11.9 M to The Burnham Institute to establish the San Diego Chemical Screening Center

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/22/2020)... ... April 21, 2020 , ... Captis Biotechnology, Inc. announced ... that provides patent development support for early stage startups. The investment will support ... ovarian cancer and precancerous pancreatic lesions with simple, accurate and practical technology. , ...
(Date:4/18/2020)... ... April 16, 2020 , ... SIRION Biotech GmbH , a world ... it will present a company update on its work expediting gene therapy research and ... on April 22 and 23. Dieter Lingelbach, the Company’s Chief Operating Officer, will also ...
(Date:4/16/2020)... , ... April 15, 2020 , ... ... working cell banks and hMSC bioprocess systems, announces that the Medical Technology Enterprise ... at MTEC’s 4th Annual Membership Meeting in March. The Regenerative Medicine (RegenMed) biomanufacturing ...
Breaking Biology News(10 mins):
(Date:5/5/2020)... ... May 05, 2020 , ... Smart Meter, ... of its iGlucose® LTE Cat-M Cellular Connected Diabetes Blood Glucose Monitor ... the industry’s newest and broadest cellular connectivity available, to provide patients with seamless ...
(Date:4/26/2020)... ... April 23, 2020 , ... Indegene Omnipresence, Inc. ... providing applications and services for use on Microsoft Azure. The customer experience management ... up online for a built-for-purpose customer engagement capability to use in their commercial ...
(Date:4/22/2020)... , ... April 20, 2020 , ... ... in Cambridge, MA, announced today that Omixon’s founder and chairman Dr. Attila Berces ... Omixon’s flagship product Holotype HLA since 2014 before stepping into the CEO role ...
(Date:4/22/2020)... (PRWEB) , ... April 21, 2020 , ... ... continue their work through COVID-19. Many clinical trial teams are working remotely and ... Ripple Science wants to help researchers continue their research during this uncertain time ...
Breaking Biology Technology:
Cached News: